Cardiac Arrhythmia Monitoring Devices Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
The global occurrence of cardiovascular diseases (CVDs) has increased tenfold over the past few decades. Growing urbanization has brought lifestyle changes such as increased intake of packaged and junk food, physical inactivity, excessive smoking, and consumption of alcohol and tobacco. The increasing burden of CVDs like atrial flutter, atrial fibrillation, and bradycardia has created a significant demand for accurate cardiac arrythmia monitoring devices for continuous diagnosis.
GMI, forecasts that global cardiac arrythmia monitoring devices market size will record a CAGR of more than 6.8% through 2026. Abbott, Medtronic, Biotronik, GE Healthcare, Philips, and Nihon Kohden are a few notable names in the industry. In July 2020, Biotronik had gained approval from the U.S. FDA for its new injectable cardiac health monitoring device Biomonitor III.
Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/2732
Cardiac healthcare devices are used for continuous monitoring and diagnosis of premature contractions, bradycardia, and tachycardia. Tachycardia application accounted for over 87% revenue share of cardiac arrythmia monitoring devices industry in 2019 and is likely to experience a commendable growth in the upcoming years. This can be attributed to the rising incidence of different types of tachycardia such as atrial fibrillation.
Tachycardia is a cardiac health problem where the heart beats faster than usual. Healthcare professional usually use Holter monitors or ECG devices for monitoring and diagnosis depending upon the type of tachycardia.
Mobile cardiac telemetry, Holter Monitor, implantable cardiac monitor, ECG monitors, and event recorders are the different types of cardiac arrythmia monitoring devices. Mobile cardia telemetry industry share is estimated to grow at over 8% CAGR through 2026.
Healthcare institutions are spending substantially on advanced mobile cardiac telemetry devices with innovative features and functionality compared to traditional cardiac healthcare devices. Modern devices can detect both symptomatic and asymptomatic cardiac arrythmias. Furthermore, mobile cardiac telemetry devices allow unrestricted movement as they can transmit data wirelessly in real time, making them desirable in cardiac health monitoring applications.
Europe cardiac arrhythmia monitoring devices industry size was valued at US$1.7 billion in 2019 and is projected to record substantial gains over the next few years. The regional demand for cardiac healthcare devices will mainly be influenced by the presence of some of the most renowned healthcare companies and growing penetration of new entrants.
European countries are home to a large elderly population base. As a result, these countries are observing a gradual rise in the number of chronic heart disorders. Several factors such as obesity, excessive smoking, and unhealthy lifestyles have increased the risk of cardiac conditions among the adult population. A large number of COVID-19 patients in Europe will certainly boost the demand for reliable and accurate remote cardiac health monitoring devices.
Cardiac healthcare devices and equipment have been extensively used across diagnostic centers, hospitals, clinics, and ambulatory surgical centers. However, these devices have gained traction in homecare settings in recent years. The sales of cardiac arrythmia monitoring devices across home care settings are expected to hit an annual valuation of US$950 million by 2026.
The popularity of remote healthcare devices has increased significantly over the past several years, particularly across emerging economies. Today, most cardiac healthcare device makers are focusing on development of wearables to enable continuous cardiac monitoring for patients at the comfort at their homes. With rising income levels, consumer inclination towards homecare cardiac health monitoring devices is likely to increase.
Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/cardiac-arrhythmia-monitoring-devices-market
Partial Chapter of the Table of Content
Chapter 4. Cardiac Arrhythmia Monitoring Devices Market, By Device
4.1. Key segment trends, by devices
4.2. Holter monitor
4.2.1. Market size, by region, 2015 – 2026 (USD Million)
4.3. Event recorder
4.3.1. Market size, by region, 2015 – 2026 (USD Million)
4.4. Mobile cardiac telemetry
4.4.1. Market size, by region, 2015 – 2026 (USD Million)
4.5. Implantable cardiac monitor
4.5.1. Market size, by region, 2015 – 2026 (USD Million)
4.6. Electrocardiogram (ECG) monitor
4.6.1. Market size, by region, 2015 – 2026 (USD Million)
4.7.1. Market size, by region, 2015 – 2026 (USD Million)
Chapter 5. Cardiac Arrhythmia Monitoring Devices Market, By Application
5.1. Key segment trends, by application
5.2.1. Market size, by region, 2015 - 2026 (USD Million)
5.2.2. Atrial tachycardia
184.108.40.206. Market size, by region, 2015 - 2026 (USD Million)
5.2.3. Ventricular tachycardia
220.127.116.11. Market size, by region, 2015 - 2026 (USD Million)
5.3.1. Market size, by region, 2015 - 2026 (USD Million)
5.4. Premature contractions
5.4.1. Market size, by region, 2015 - 2026 (USD Million)
5.5.1. Market size, by region, 2015 - 2026 (USD Million)